Chen L, Chen X, Ruan B, Yang H, Yu Y
Retatrutide is a triple-receptor agonist (GIP, GLP-1, and glucagon) while Tirzepatide is a dual-receptor agonist (GIP and GLP-1)
European Journal of Nutrition , 56 (3), 10631076
This pricing dynamic constrains overall market penetration and slows adoption despite the strong clinical benefits of GLP-1 therapies in weight management and glycemic control, making cost a key obstacle to broader global uptake
Can Tirzepatide Treat Type 2 Diabetes
The International Society of Sports Nutrition position stand says most exercising people can support muscle-building and muscle-maintenance goals with roughly 1.4-2.0 grams of protein per kilogram of body weight per day, with 20-40 grams of high-quality protein being a common per-serving target